FdaApplication
ANDA 204237
Identifiers
- fda_app_no: ANDA204237
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2015-11-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RABEPRAZOLE SODIUM | RABEPRAZOLE SODIUM | 20MG | TABLET, DELAYED RELEASE;ORAL |
1 product